1 completed. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
Follow immunologic technique: new trials by email Literature Review of immunologic technique trials Research Report on immunologic technique
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer CpG oligodeoxynucleotide, HER-2/neu peptide vaccine, MUC-1 peptide vaccine - Breast Cancer | Early Phase 1 | Completed | Mayo Clinic | 45 | 2008-08-28 | 2018-10-31 |
Breast Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Mayo Clinic (1)
United States (1)
Barbara A Pockai, M.D. (1) · Edith A Perez, M.D. (1) · Svetomir Markovic, MD, PhD (1)
P30CA015083 (1)